ADRB2 expression in HCC tissues is associated with several poor prognostic factors and is an independent prognostic factor for RFS and OS in surgically curable HCC.[43, 44] Hence, immunohistochemical staining of ADRB2 expression may provide useful information for considering NSBB treatment. Here, ADRB2 is linked to hepatocellular carcinoma.